Supreme Court decides the patent suit of Lyrica on 14th
The final decision of the patent suit for the use patent of the Lyrica(Pfizer), a large-scale painkiller, will be made on the 14th.
The Supreme Court will announce the decision on the action of nullity of the Lyrica’s use patent, filed by CJ HealthCare and Samjin Pharm, on the 14th.
The fight a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
